• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)

  • Print
  • Share
  • E-mail
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC

New Search Back to Search Results
Note: this medical device record is a supplement. The device description may have changed. Be sure to look at the original PMA to get an up-to-date view of this device.
Classification Namecatheters, transluminal coronary angioplasty, percutaneous
Generic Namecatheters, transluminal coronary angioplasty, percutaneous
Regulation Number870.5100
one scimed place
maple grove, MN 55311-1566
PMA NumberP860019
Supplement NumberS113
Date Received05/02/1996
Decision Date04/09/1997
Product Code
LOX[ Registered Establishments with LOX ]
Advisory Committee Cardiovascular
Supplement Typenormal 180 day track
Supplement Reason change design/components/specifications/material
Expedited Review Granted? No
Combination Product No
Approval Order Statement 
Approval for a new balloon dilatation and infusion catheter. The device will be marketed under the trade name scimed(r) transport(r) coronary balloon dilatation-infusion catheter and is indicatd for balloon dilatation of the stenotic portion of a coronary artery or bypass graft stenosis fo rthe purpose of improving myocardial perfusion. The transport(r) catheter is also intended to infusion fluids such as heparinized saline, and thrombolytic agents such as urokinase, intot eh vasculature when the dilatation balloon is deflated or inflated to pressures up to 3 atmospheres.